Stock listing

NASDAQ:JUNO Juno Therapeutics Inc Stock

Follow Juno Therapeutics Inc into a list and get an email when it puts out news.

Last close · NASDAQ:JUNO

$86.96 USD

Close on Mar 5, 2018 · No longer trades

Dec 19, 2014 to last close +148.5% · weekly closes, Dec 19, 2014 – Mar 5, 2018
Lowest – highest close
$17.86 – $86.96 USDSince Dec 19, 2014 · lowest Dec 13, 2016 · highest Mar 5, 2018

Delisted NASDAQ:JUNO no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.

Ticker
NASDAQ:JUNO
Asset type
Stock
Exchange
NASDAQ
Currency
USD

Juno Therapeutics Inc on 6ix

Decks
7 decks · latest Jan 9, 2017

Decks

DeckKindSlidesDate
Investor Presentation (January 2017)Investor deck18 slidesJan 9, 2017
Investor Presentation (September 2016)Investor deck19 slidesSep 13, 2016
Investor Presentation (July 2016)Investor deck28 slidesJul 7, 2016
Investor Presentation (June 2016)Investor deck27 slidesJun 7, 2016
Investor Presentation (March 2016)Investor deck27 slidesMar 8, 2016
Investor Presentation (January 2016)Investor deck20 slidesJan 11, 2016
Investor Presentation (September 2015)Investor deck25 slidesSep 15, 2015

Open Decks

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Robert Azelby
Other companies: Tango Therapeutics, Inc. (Chairman; Former President and CEO, Eliem Therapeutics, Inc. · Since at least Jun 19, 2026); Autolus Therapeutics plc (Director · Since at least Mar 18, 2026); Terns Pharmaceuticals, Inc. (Director · Since at least Feb 20, 2025); Cardinal Health, Inc. (Director · Since at least Mar 1, 2024); ADC Therapeutics SA (Director · Since at least Jan 2, 2024); Aduro Biotech Inc (Director · Apr 10, 2023 – Aug 11, 2023 · Past); Climb Bio, Inc. (President & CEO, Director · Aug 9, 2021 – Oct 31, 2022 · Past); Immunomedics Inc (Director · Feb 26, 2020 – Oct 23, 2020 · Past); Clovis Oncology Inc (Director · Oct 11, 2018 – Jun 10, 2021 · Past); Alder BioPharmaceuticals Inc (President and CEO, Director · Jun 13, 2018 – Oct 22, 2019 · Past); Cascadian Therapeutics Inc (Director · Mar 31, 2017 – Mar 9, 2018 · Past)
EVP & Chief Commercial Officer · Nov 1, 2015 – Mar 5, 2018 · Past
Jay Flatley
Other companies: Rivian Automotive, Inc. (Member · Since at least Nov 9, 2021); Denali Therapeutics Inc. (Director · Since at least Dec 7, 2017); Senti Biosciences Holdings, Inc. (Director · May 25, 2021 – May 25, 2021 · Past); Zymergen Inc (Chairman and Acting CEO, Director · Apr 21, 2021 – Oct 19, 2022 · Past); Coherent Corp. (Director · Sep 20, 2011 – Jul 1, 2022 · Past); Illumina, Inc. (Director · Jan 10, 2006 – May 18, 2021 · Past)
Director · May 22, 2017 – Mar 5, 2018 · Past
Sunil Agarwal
Other companies: Astria Therapeutics Inc (Director · Since at least Apr 5, 2024); Arvinas, Inc. (Director · Since at least Jun 15, 2023); Sana Biotechnology, Inc. (EVP, Head of Development & CMO · Feb 3, 2021 – Mar 3, 2022 · Past); MyoKardia Inc (Director · Mar 4, 2016 – Nov 17, 2020 · Past); Calithera Biosciences, Inc. (Director · Sep 29, 2015 – Jun 1, 2022 · Past); Ultragenyx Pharmaceutical Inc. (Chief Medical Officer · Aug 19, 2015 – Aug 19, 2016 · Past)
President of R & D · Apr 13, 2017 – Mar 5, 2018 · Past
Thomas Daniel
Other companies: Gossamer Bio, Inc. (Director · Since at least Feb 7, 2019); Dianthus Therapeutics, Inc. (Director · Jun 20, 2018 – Jun 28, 2022 · Past); Larimar Therapeutics, Inc. (Director · Mar 3, 2016 – May 12, 2021 · Past); Epizyme Inc (Director · May 30, 2013 – May 30, 2013 · Past); Celgene Corporation (see remarks · Feb 15, 2012 – Dec 31, 2015 · Past)
Director · Aug 11, 2015 – Mar 5, 2018 · Past
Hans Bishop
Other companies: Sana Biotechnology, Inc. (Chairman · Since at least Feb 3, 2021); Lyell Immunopharma, Inc. (Director · Jun 16, 2021 – Jun 14, 2024 · Past); Celgene Corporation (Director · Apr 18, 2018 – Nov 20, 2019 · Past); Agilent Technologies, Inc. (Director · Jul 18, 2017 – Mar 15, 2024 · Past)
CEO & President, Director · Jun 9, 2016 – Mar 5, 2018 · Past
Harold Hal Barron
Other companies: Quantinuum Inc. (Independent Director · Since at least Jun 4, 2026); Alexza Pharmaceuticals Inc (Director · Dec 19, 2007 – May 21, 2013 · Past); Genentech Inc (SVP - DEVELOPMENT & CMO · Dec 18, 2007 – Mar 26, 2009 · Past)
Director · Dec 18, 2014 – Mar 5, 2018 · Past
Mark W. Frohlich
Other companies: Rigel Pharmaceuticals, Inc. (Director · Since at least Mar 6, 2025); Dendreon Corp (EVP, R&D and CMO · Apr 3, 2013 – Jan 20, 2014 · Past)
See Remarks · Dec 18, 2014 – Feb 29, 2016 · Past
Ann Lee
Other companies: Prime Medicine, Inc. (Chief Technical Officer · Since at least Oct 19, 2022)
EVP, Technical Operations · Nov 25, 2017 – Mar 5, 2018 · Past

Open People

Log in to ask 6ix AI your own questions about Juno Therapeutics Inc.